Form of presentation | Articles in international journals and collections |
Year of publication | 2015 |
Язык | английский |
|
Nikolskiy Evgeniy Evgenevich, author
Petrov Konstantin Aleksandrovich, author
|
Bibliographic description in the original language |
Kharlamova A.D. Etiopathogenesis and principles of myasthenia gravis treatment (Review)/ A.D. Kharlamova, K.A. Petrov, I.V. Zueva, E.E. Nikolsky // Genes and Cells, Volume 10, Issue 4, 1 December 2015, Pages 15-19 |
Annotation |
The review addresses issues of etiological studies of synaptic defects underlying severe immunological disease of neuromuscular system myasthenia gravis. Current concepts on molecular mechanisms of muscle weakness accompanying this disease are considered, development of new algorithms of myasthenia gravis treatment is discussed. |
Keywords |
Autoimmune diseases; Myasthenia gravis; Synaptic transmission |
The name of the journal |
Genes and Cells
|
URL |
http://www.scopus.com/inward/record.url?eid=2-s2.0-84962280839&partnerID=40&md5=f48e1a242a2f607aaf8214f513c11ca6 |
Please use this ID to quote from or refer to the card |
https://repository.kpfu.ru/eng/?p_id=136023&p_lang=2 |
Full metadata record ![](https://shelly.kpfu.ru/pdf/picture/arrow_black_right.gif) |
Field DC |
Value |
Language |
dc.contributor.author |
Nikolskiy Evgeniy Evgenevich |
ru_RU |
dc.contributor.author |
Petrov Konstantin Aleksandrovich |
ru_RU |
dc.date.accessioned |
2015-01-01T00:00:00Z |
ru_RU |
dc.date.available |
2015-01-01T00:00:00Z |
ru_RU |
dc.date.issued |
2015 |
ru_RU |
dc.identifier.citation |
Kharlamova A.D. Etiopathogenesis and principles of myasthenia gravis treatment (Review)/ A.D. Kharlamova, K.A. Petrov, I.V. Zueva, E.E. Nikolsky // Genes and Cells, Volume 10, Issue 4, 1 December 2015, Pages 15-19 |
ru_RU |
dc.identifier.uri |
https://repository.kpfu.ru/eng/?p_id=136023&p_lang=2 |
ru_RU |
dc.description.abstract |
Genes and Cells |
ru_RU |
dc.description.abstract |
The review addresses issues of etiological studies of synaptic defects underlying severe immunological disease of neuromuscular system myasthenia gravis. Current concepts on molecular mechanisms of muscle weakness accompanying this disease are considered, development of new algorithms of myasthenia gravis treatment is discussed. |
ru_RU |
dc.language.iso |
ru |
ru_RU |
dc.subject |
|
ru_RU |
dc.title |
AEtiopathogenesis and principles of myasthenia gravis treatment (Review) |
ru_RU |
dc.type |
Articles in international journals and collections |
ru_RU |
|